Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression.

Autor: Jajosky RP; Department of Pathology, Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Glycomics Center, Harvard Medical School, Boston, MA., Patel KR; Department of Pathology, Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Boston, MA., Allen JWL; Department of Pathology, Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Boston, MA., Zerra PE; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA., Chonat S; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA., Ayona D; Department of Pathology, Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Boston, MA., Maier CL; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA., Morais D; Department of Pathology, Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Boston, MA., Wu SC; Department of Pathology, Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Boston, MA., Luckey CJ; Department of Pathology, University of Virginia, Charlottesville, VA., Eisenbarth SC; Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT.; Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL., Roback JD; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA., Fasano RM; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA., Josephson CD; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA.; Department of Hematology and Oncology, Johns Hopkins University All Children's Hospital, St. Petersburg, FL.; Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St. Petersburg, FL.; Departments of Oncology and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD., Manis JP; Department of Laboratory Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA., Chai L; Department of Pathology, Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Boston, MA., Hendrickson JE; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA.; Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT., Hudson KE; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York City, NY., Arthur CM; Department of Pathology, Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Glycomics Center, Harvard Medical School, Boston, MA., Stowell SR; Department of Pathology, Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Glycomics Center, Harvard Medical School, Boston, MA.

Publikováno v: Blood [Blood] 2023 Sep 21; Vol. 142 (12), pp. 1082-1098.

Marginal zone B cells mediate a CD4 T-cell-dependent extrafollicular antibody response following RBC transfusion in mice.

Autor: Zerra PE; Center for Transfusion Medicine and Cellular Therapies, Department of Laboratory Medicine and Pathology, and.; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA and., Patel SR; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA and., Jajosky RP; Center for Transfusion Medicine and Cellular Therapies, Department of Laboratory Medicine and Pathology, and.; Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and., Arthur CM; Center for Transfusion Medicine and Cellular Therapies, Department of Laboratory Medicine and Pathology, and., McCoy JW; Center for Transfusion Medicine and Cellular Therapies, Department of Laboratory Medicine and Pathology, and., Allen JWL; Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and., Chonat S; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA and., Fasano RM; Center for Transfusion Medicine and Cellular Therapies, Department of Laboratory Medicine and Pathology, and.; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA and., Roback JD; Center for Transfusion Medicine and Cellular Therapies, Department of Laboratory Medicine and Pathology, and., Josephson CD; Center for Transfusion Medicine and Cellular Therapies, Department of Laboratory Medicine and Pathology, and.; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA and., Hendrickson JE; Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT., Stowell SR; Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and.

Publikováno v: Blood [Blood] 2021 Aug 26; Vol. 138 (8), pp. 706-721.

Serum pooling for rapid expansion of anti-SARS-CoV-2 antibody testing capacity.

Autor: Allen JWL; Department of Laboratory Medicine and Pathology, Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, 201, Dowman Dr, 30322 Atlanta, GA, United States; Department of Pathology, Joint Program in Transfusion Medicine, Harvard Medical School, Brigham and Women's Hospital, 630D New Research Building, 02115 Boston, MA, United States., Verkerke H; Department of Laboratory Medicine and Pathology, Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, 201, Dowman Dr, 30322 Atlanta, GA, United States; Department of Pathology, Joint Program in Transfusion Medicine, Harvard Medical School, Brigham and Women's Hospital, 630D New Research Building, 02115 Boston, MA, United States., Owens J; Department of Laboratory Medicine and Pathology, Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, 201, Dowman Dr, 30322 Atlanta, GA, United States., Saeedi B; Department of Laboratory Medicine and Pathology, Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, 201, Dowman Dr, 30322 Atlanta, GA, United States., Boyer D; Department of Laboratory Medicine and Pathology, Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, 201, Dowman Dr, 30322 Atlanta, GA, United States., Shin S; Department of Laboratory Medicine and Pathology, Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, 201, Dowman Dr, 30322 Atlanta, GA, United States., Roback JD; Department of Laboratory Medicine and Pathology, Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, 201, Dowman Dr, 30322 Atlanta, GA, United States., Neish AS; Department of Laboratory Medicine and Pathology, Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, 201, Dowman Dr, 30322 Atlanta, GA, United States., Stowell SR; Department of Laboratory Medicine and Pathology, Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, 201, Dowman Dr, 30322 Atlanta, GA, United States; Department of Pathology, Joint Program in Transfusion Medicine, Harvard Medical School, Brigham and Women's Hospital, 630D New Research Building, 02115 Boston, MA, United States. Electronic address: srstowell@bwh.harvard.edu.

Publikováno v: Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine [Transfus Clin Biol] 2021 Feb; Vol. 28 (1), pp. 51-54. Date of Electronic Publication: 2020 Oct 21.

Fc Gamma Receptors and Complement Component 3 Facilitate Anti-fVIII Antibody Formation.

Autor: Zerra PE; Department of Pathology and Laboratory Medicine, Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, Atlanta, GA, United States.; Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta and Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States., Arthur CM; Department of Pathology and Laboratory Medicine, Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, Atlanta, GA, United States., Chonat S; Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta and Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States., Maier CL; Department of Pathology and Laboratory Medicine, Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, Atlanta, GA, United States., Mener A; Department of Pathology and Laboratory Medicine, Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, Atlanta, GA, United States., Shin S; Department of Pathology and Laboratory Medicine, Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, Atlanta, GA, United States., Allen JWL; Department of Pathology and Laboratory Medicine, Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, Atlanta, GA, United States., Baldwin WH; Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta and Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States., Cox C; Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta and Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States., Verkerke H; Department of Pathology and Laboratory Medicine, Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, Atlanta, GA, United States., Jajosky RP; Department of Pathology and Laboratory Medicine, Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, Atlanta, GA, United States., Tormey CA; Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT, United States.; Pathology and Laboratory Medicine Service, VA Conneciticut Healthcare System, West Haven, CT, United States., Meeks SL; Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta and Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States., Stowell SR; Department of Pathology and Laboratory Medicine, Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, Atlanta, GA, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2020 Jun 09; Vol. 11, pp. 905. Date of Electronic Publication: 2020 Jun 09 (Print Publication: 2020).